Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05873751 · ClinicalTrials.gov registry record
A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 1,307,378
- Enrollment target
NCT05873751: Completed study, sponsored by Pfizer.
NCT05873751 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 1,307,378 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05873751 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 1,307,378 participants
- Enrollment target
Study Summary
Brief Summary: The main purpose of the study is to learn about how well Trumenba vaccine shot works against gonorrhea infection. This study looks at data records from a database in the United States. This study includes patient's data from the database who: * Are 15-30 years old. * Have received at least one dose of Trumenba and a MenACWY vaccine or who have received only MenACWY vaccine. This data has already been collected in the past and is being studied between April and June of 2023.
Primary Outcome
Number of participants (cases) with infection of interest were reported. If a participant had repeated infection only first occurrence was considered, hence one participant with infection was counted only once. VE was calculated as 1 minus the hazard ratio (HR) multiplied by 100. VE is reported as part of statistical data in this outcome measure. The index date (zero time) was the date of the last dose of Trumenba vaccination, after at least one dose of MenACWY for the exposed cohort and first d
Interventions
- BIOLOGICAL Trumenba Vaccine
- BIOLOGICAL MenACWY Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,307,378 participants |
| Start Date | 2023-04-24 |
| Est. Completion | 2024-03-31 |
What the finished NCT05873751 record still lists
NCT05873751 is an observational study that tracks outcomes without assigning an intervention. Its 1,307,378 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Trumenba Vaccine is the first listed.
NCT05873751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05873751 about?
NCT05873751 is a clinical study titled "A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.". Brief Summary: The main purpose of the study is to learn about how well Trumenba vaccine shot works against gonorrhea infection. This study looks at data records from a database in the United States. This study includes patient's data from the database who: * Are 15-30 years old. * Have received...
What is the current status of trial NCT05873751?
This trial is currently completed. The enrollment target is 1,307,378 participants. The study started on 2023-04-24. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT05873751?
The interventions under investigation include: Trumenba Vaccine (BIOLOGICAL), MenACWY Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05873751?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07022951 · 1,200,000 participants
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
- NCT05066763 · 1,000,000 participants
Parkinson's Foundation Surveys
- NCT07075341 · 1,000,000 participants
Healthy Living BEYOND Weight Study
- NCT07224685 · 1,000,000 participants
A Study of Mayo Clinic CV Research Heart & Voice Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI